https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-34
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-07-01 / Eur. J. Cancer 2001 Jul;37(11):1429-342001-07-01 00:00:002019-02-15 08:39:25Enhancement of the therapeutic outcome of radio-immunotherapy by combination with whole-body mild hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-06-21 / MMW Fortschr Med 2001 Jun;143(25):28-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-06-21 / MMW Fortschr Med 2001 Jun;143(25):28-322001-06-21 00:00:002019-02-15 09:17:56[Addition of hyperthermia. Heat potentiates cancer therapy]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-05-01 / Eur. J. Immunol. 2001 May;31(5):1602-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-05-01 / Eur. J. Immunol. 2001 May;31(5):1602-92001-05-01 00:00:002019-02-15 09:18:06The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-02-01 / Onkologie 2001 Feb;24(1):55-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-02-01 / Onkologie 2001 Feb;24(1):55-82001-02-01 00:00:002019-02-15 09:17:56Posttreatment histology and microcirculation status of osteogenic sarcoma after a neoadjuvant chemo- and radiotherapy in combination with local electromagnetic hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Cancer Invest. 2001;19(8):791-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Cancer Invest. 2001;19(8):791-82001-01-01 00:00:002001-01-01 00:00:00Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-08-01 / Eur. J. Immunol. 2000 Aug;30(8):2211-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-08-01 / Eur. J. Immunol. 2000 Aug;30(8):2211-52000-08-01 00:00:002019-02-15 09:18:07The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-07-15 / Cancer 2000 Jul;89(2):399-403
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-07-15 / Cancer 2000 Jul;89(2):399-4032000-07-15 00:00:002019-02-15 10:00:40External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-06-05 / J. Exp. Med. 2000 Jun;191(11):1957-64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-06-05 / J. Exp. Med. 2000 Jun;191(11):1957-642000-06-05 00:00:002019-02-15 09:18:05Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-05-01 / Immunol. Invest. 2000 May;29(2):139-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-05-01 / Immunol. Invest. 2000 May;29(2):139-422000-05-01 00:00:002019-02-15 09:17:57Use of mild, whole body hyperthermia in cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-04-01 / Lancet 2000 Apr;355(9210):1119-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-04-01 / Lancet 2000 Apr;355(9210):1119-252000-04-01 00:00:002019-02-15 08:35:52Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group
